TSX News -
Madison Pacific Properties Inc. announces Tax Court of Canada judgement on tax court case
VANCOUVER, British Columbia, Jan. 04, 2024 (GLOBE NEWSWIRE) — Madison Pacific Properties Inc. (the Company) (TSX: MPC and MPC.C), a […]
UMH PROPERTIES, INC. 2023 YEAR END OPERATIONS UPDATE
FREEHOLD, NJ, Jan. 04, 2024 (GLOBE NEWSWIRE) — UMH Properties, Inc. (NYSE:UMH) (TASE:UMH), a real estate investment trust (REIT) specializing […]
Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial Results
SAN RAFAEL, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) — Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader […]
TSX News -
AGF Management Limited to Release Fiscal 2023 Financial Results on January 24, 2024
TORONTO, Jan. 04, 2024 (GLOBE NEWSWIRE) — AGF Management Limited (TSX: AGF.B) will release its financial results for fiscal 2023 […]
Sun Communities, Inc. Prices $500 Million of Senior Notes
Southfield, MI, Jan. 04, 2024 (GLOBE NEWSWIRE) — Sun Communities, Inc. (NYSE: SUI) (the “Company”), a real estate investment trust […]
TSX News -
AGF Reports December 2023 Assets Under Management and Fee-Earning Assets
TORONTO, Jan. 04, 2024 (GLOBE NEWSWIRE) — AGF Management Limited reported total assets under management (AUM) and fee-earning assets1 of […]
Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 Revenues
TAMPA, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to […]
ThreeD Capital Inc. Announces Investor Relations Agreement
TORONTO, Jan. 04, 2024 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQX:IDKFF) a Canadian-based venture […]
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023
ALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing […]
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook
Reported updated data from ongoing Phase 1b trial in kidney transplantation demonstrating tegoprubart treatment successfully prevented kidney transplant rejection and […]
